Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease

Low high-density lipoprotein-cholesterol (HDL-c) is the most remarkable lipid trait both in mild-to-moderate chronic kidney disease (CKD) patients as well as in advanced renal disease stages, and we have previously shown that reduced lecithin:cholesterol acyltransferase (LCAT) concentration is a maj...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Andrea Baragetti, Alice Ossoli, Arianna Strazzella, Sara Simonelli, Ivano Baragetti, Liliana Grigore, Fabio Pellegatta, Alberico L. Catapano, Giuseppe Danilo Norata, Laura Calabresi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2020-07-01
Saila:Journal of Clinical Medicine
Gaiak:
lecithin:cholesterol acyltransferase
chronic kidney disease
high-density lipoproteins
Sarrera elektronikoa:https://www.mdpi.com/2077-0383/9/7/2289
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak